CORE Biomedicine Partners with Eisai to Enhance Precision Oncology Efforts Globally#USA#Boston#Eisai#Oncology_Programs#CORE_Biomedicine
CORE Biomedicine Partners with Eisai to Enhance Precision Oncology Efforts Globally
CORE Biomedicine has secured an exclusive licensing agreement with Eisai to advance precision oncology programs aimed at cancer treatment, enhancing global health initiatives.
third-news.com
July 28, 2026 at 12:43 PM
CORE Biomedicine Partners with Eisai to Enhance Precision Oncology Efforts Globally#USA#Boston#Eisai#Oncology_Programs#CORE_Biomedicine
Lupin Limited Advances Oncology Strategy with Kaveri Therapeutics Partnership#India#Mumbai#Lupin_Limited#Kaveri_Therapeutics#Oncology_Programs
Lupin Limited Advances Oncology Strategy with Kaveri Therapeutics Partnership
Lupin Limited has announced the spin-out of two oncology programs to Kaveri Therapeutics, a move set to strengthen its oncology strategy and fund global trials.
third-news.com
July 21, 2026 at 5:08 AM
Lupin Limited Advances Oncology Strategy with Kaveri Therapeutics Partnership#India#Mumbai#Lupin_Limited#Kaveri_Therapeutics#Oncology_Programs